Aortic perivascular adipose tissue (aPVAT) promotes age-related aortic stiffening in preclinical animal models, but the relation between aPVAT density and cardiovascular function in adults is unknown. We demonstrate that aPVAT, but not abdominal visceral adipose tissue density, is positively associated with aging, aortic stiffness, and higher resting aortic blood pressure in apparently healthy adults. These findings provide novel evidence for aPVAT as a viable therapeutic target for improving cardiovascular function in humans.
29 May 2021 in Clinical Physiology and Functional Imaging
The purpose of this review is to provide a concise overview of the polyphenol curcumin for improving arterial health, specifically endothelial function and arterial stiffness, to reduce cardiovascular disease (CVD) risk and to highlight potential mechanisms of action by which curcumin may improve artery function. The primary findings of this review support the notion for curcumin to improve arterial health both with aging and obesity. There are few clinical trials on curcumin, and those that currently exist are small in scale but provide evidence for curcumin to improve endothelial function in older adults and reduce arterial stiffness in young, obese men. The antioxidant and anti-inflammatory properties of curcumin appear to be important targets of curcumin that are related to improved arterial health. Mechanistic studies have revealed superoxide dismutase, heme oxygenase-1 and nuclear factor erythroid 2-related factor 2 as emerging targets for the beneficial effects of curcumin on the vasculature. In summary, the efficacy of curcumin for improving arterial function is promising in the limited number of clinical studies performed to date. Still, much investigation is needed to elucidate the effectiveness of curcumin for improving arterial health to lower CVD risk.
Nutraceutical-based interventions hold promise to reduce blood pressure (BP) and arterial stiffness, which are two cardiovascular disease (CVD) risk factors. However, the effects of coconut sap powder (CSP), an Asian sweetener and novel nutraceutical, on BP and arterial stiffness in middle-aged and older adults (MA/O, ≥ 45 y) has yet to be established. We hypothesized CSP will decrease BP and arterial stiffness in MA/O adults. In a double-blind, randomized, placebo-controlled study design, nineteen (age 55.3 ± 2.1 y) MA/O adults completed measures of brachial and carotid BP, and arterial stiffness (carotid-femoral pulse wave velocity [cfPWV], common carotid artery (CCA) β-stiffness, compliance, distensibility, and Young's and Peterson's Elastic moduli) before and after 8 weeks of CSP (1.5 g/day) or placebo (1.5 g/day). A two-way repeated measures analysis of variance was used to compare group mean differences. Compared to placebo, CSP lowered brachial systolic BP (SBP) (CSP pre: 117.4 ± 2.9 vs post: 109.0 ± 2.4 mmHg, p<0.05), but not carotid SBP (p=0.12). CSP also lowered Youngs (CSP pre: 5514.4 ± 1115.4 vs post: 3690.6 ± 430.9 kPa) and Peterson's Elastic moduli (CSP pre: 22.2 ± 4.4 vs post: 19.2 ± 4.5 kPa) (p0.05). No inflammatory or antioxidant biomarkers were affected by CSP. In summary, 8 weeks of CSP lowers brachial SBP and CCA mechanical stiffness indicating a potential cardioprotective effect in MA/O adults.
1 August 2025 in American Journal of Physiology-Endocrinology and Metabolism
This study demonstrates that aging alters the transcriptional landscape of PBMCs at rest and in response to acute high-intensity exercise. Older adults exhibited greater transcriptomic responsiveness to exercise, particularly in pathways related to immune signaling and cellular stress. Notably, exercise elicited shared activation of NK cell-mediated processes across age groups, suggesting a conserved immunomodulatory effect. These findings provide molecular insight into how aging and exercise interact to shape immune cell function.